Leptin in the 21st CenturyLeptin treatment: Facts and expectations
Under a Creative Commons license
open access
Abbreviations
ALT
alanine transaminase
AST
aspartate transaminase
BMI
body mass index
CLD
congenital leptin deficiency
Cmax
peak serum concentration
CYP450
cytochrome P450
DXA
dual-energy X-ray absorptiometry
FGF21
fibroblast growth factor 21
FSH
follicle-stimulating hormone
GH
growth hormone
GnRH
gonadotropin-releasing hormone
HAART
highly active antiretroviral therapy
HbA1c
hemoglobin A1c
IGF-1
insulin-like factor-1
IGFBP
insulin-like growth factor-binding protein
LH
luteinizing hormone
LRT
leptin replacement therapy
NAFLD
nonalcoholic fatty liver disease
NASH
nonalcoholic steatohepatitis
Nf-κB
nuclear factor kappa-light-chain-enhancer of activated B cells
SOCS3
suppressor of cytokine signaling-3
POMC
proopiomelanocortin
PTP1B
protein tyrosine phosphatase 1B
Tmax
time to the maximum concentration
TNFα
tumor necrosis factor α
TSH
thyroid stimulating hormone
Keywords
Congenital leptin deficiency
Leptin
Metreleptin
Myalept
Obesity
Cited by (0)
- 1
Garran Rd, Building 131, Acton, ACT 0200, Australia.
- 2
South Australian Health and Medical Research Institute, PO Box 11060, Adelaide, SA 5001, Australia.
Copyright © 2015 The Authors. Published by Elsevier Inc.